Evidence map›Paper›PMID 40983695›Full record

ArticleNature aging2025

An International Working Group viewpoint on stratifying risk and prevention of the clinical expression of Alzheimer's disease.

Howard H Feldman, Nicolas Villain, Giovanni B Frisoni, Bruno Dubois

Abstract read
PubMed Publisher
In one paragraph

Article in Nature aging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Substituting blood-based biomarkers for imaging measures in Alzheimer's disease studies: implications for sample size and bias.The journals of gerontology. Series A, Biological sciences and medical sciences · 2026
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Howard H FeldmanAlzheimer's Disease Cooperative Study, University of California San Diego, School of Medicine, La Jolla, CA, USA. howardfeldman@health.ucsd.edu.ORCID http://orcid.org/0000-0002-9258-4538
Nicolas VillainSorbonne Université, INSERM U1127, CNRS 7225, Institut du Cerveau - ICM, Paris, France.ORCID http://orcid.org/0000-0002-7429-4289
Giovanni B FrisoniUniGE, Geneva, Switzerland.ORCID http://orcid.org/0000-0001-7075-7082
Bruno DuboisSorbonne Université, INSERM U1127, CNRS 7225, Institut du Cerveau - ICM, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.